Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine versus sufentanil combined with ropivacaine for epidural labor analgesia
ChiCTR1800018810Phase 4Not yet recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nalbuphine, sufentanil and ropivacaine in labor pain (2 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: Time to first patient-controlled analgesia request. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
nalbuphinesufentanilropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR1800018810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018810.